Logistical Resources, LLC (LRC) is a Missouri-based licensed wholesale drug distributor and third-party logistics (3PL) provider. LRC supports pharmaceutical sourcing and vendor-direct fulfillment while recognizing the importance of authorized trading partners, product integrity, and Drug Supply Chain Security Act (DSCSA) requirements.
LRC credentials and scope: LRC holds Missouri wholesale drug distributor and 3PL licenses and reports NABP Drug Distributor Accreditation (formerly VAWD). LRC does not hold a DEA registration and does not represent that it is authorized to distribute controlled substances. Specific license categories, accreditation status, state permissions, and trading-partner roles should be independently verified for each transaction. NABP accreditation is not an FDA license or government endorsement.
How pharmaceutical ownership and physical delivery work
A direct shipment does not necessarily mean a direct sale. Title (legal ownership) and physical custody can follow different paths. The examples below are illustrative, not a statement that every LRC order uses the same structure.
Model A · Wholesale resale with vendor-direct shipping
Authorized supplier→ title →LRC · wholesaler→ title →Eligible buyer
Authorized supplier──── physical shipment ────→Eligible buyer
When LRC actually buys and resells covered prescription drugs, ownership may pass through LRC even if the vendor ships the order directly to the customer. Appropriate authorization, product tracing, records, and transaction information/statements must follow the actual ownership transactions, subject to applicable exclusions and FDA policies.
Model B · Third-party logistics without ownership
Product owner / seller→ title →Eligible buyer
Product owner→ logistics instruction →3PL coordinator
Shipping facility──── physical shipment ────→Eligible buyer
In a qualifying 3PL arrangement, the logistics provider does not take title or control the sale/disposition. The product owner and other authorized trading partners remain responsible for their applicable ownership-based DSCSA duties; 3PL licensing and other requirements may still apply.
Transaction-specific review: Purchase orders, invoices, title terms, seller-of-record details, facility roles, state licensure, and DSCSA records determine the actual regulatory responsibilities. A license alone does not establish authorization for every product, destination state, or activity. LRC does not claim DEA registration or controlled-substance distribution authority.
LRC pharmaceutical credentials and limitations
- Missouri wholesale drug distributor license: LRC holds this state authorization; current status and scope should be verified with the Missouri Board of Pharmacy.
- Missouri 3PL license: LRC holds a 3PL license; 3PL activities are distinct from taking ownership as a wholesaler.
- NABP Drug Distributor Accreditation (formerly VAWD): LRC reports holding this accreditation. Accreditation is distinct from state licensure and DEA registration; buyers may verify current accreditation standing directly with NABP.
- DEA: LRC does not hold a DEA registration. No controlled-substance distribution authorization is claimed.
Drug Supply Chain Security Act (DSCSA)
The DSCSA, enacted as part of the Drug Quality and Security Act, establishes requirements intended to improve the tracing and security of certain prescription drugs as they move through the U.S. supply chain. Applicability and implementation details depend on the product, trading-partner role, and current FDA guidance.
Authorized trading partners
Manufacturers, repackagers, wholesale distributors, dispensers, and third-party logistics providers have role-specific requirements. Parties should verify the applicable registration or licensing status of their trading partners.
Transaction information & statements
For covered transactions, DSCSA requirements address electronic, interoperable exchange of transaction information and transaction statements, subject to applicable exemptions and FDA policies.
Product identifiers & verification
Covered prescription-drug packages generally use product identifiers that support verification and tracing. Suspect and illegitimate product procedures are important safeguards.
Exceptions and investigations
Trading partners must follow applicable procedures for suspect or illegitimate products, including quarantine, investigation, and notifications when required.
Understanding product ownership transfers
Under DSCSA, a transaction generally involves a transfer of product between persons in which a change of ownership occurs, subject to statutory exclusions. The terms transaction information and transaction statement describe records exchanged for covered transactions. A shipment directly from a supplier to an end customer does not, by itself, establish who took title to the product.
Vendor-direct fulfillment: The physical ship-from address may differ from the seller of record. The parties must determine which entity buys, sells, owns, ships, or provides logistics services, and which DSCSA and state-law duties apply. A drop-shipping arrangement does not automatically remove regulatory responsibilities.
FDA regulation versus state licensing
- FDA administers federal requirements, including DSCSA obligations for applicable trading partners.
- Wholesale distributor and third-party logistics provider licensing and reporting obligations can also arise under federal and state law.
- NABP accreditation is distinct from state licensure, DEA registration, or an FDA license or endorsement.
- Controlled substances, temperature-sensitive products, and other specialized products may have additional requirements.
Buyer guidance: Before placing a pharmaceutical order, confirm the product type, licensed parties, state of destination, applicable transaction records, and responsibility for returns or product investigations. Do not submit patient information through the public RFQ form.
Discuss your procurement requirements
Tell us what you need sourced, your specifications, quantities, and delivery requirements.
REQUEST A QUOTE →Official reference resources
Information is educational and may change. Contract-specific clauses, licensing status, and current agency guidance control.